x

Adhera Therapeutics, Inc. (OTC:ATRX)

Health Care/Life Sciences • Biotechnology
CIK 737207
Company

Adhera Therapeutics, Inc. is an emerging specialty biotech company, which is in the process of evaluating its focus including a return to drug discovery and development. The company was founded on September 23, 1983 and is headquartered in Baton Rouge, LA.

Address
8000 Innovation Parkway
Baton Rouge, Louisiana 70820
Employees
None
Stock Info
Close
$0.0142
Day Range
0.0142 - 0.0149
52 Week Range
0.0065 - 0.8800
Average volume
121.9K
Short Interest
N/A (N/A)
% of Float Shorted
N/A
Market Cap
$102.54K
Revenue
N/A
Net Income
-$2.11M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.2497
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Vice Chairman & Chief Operating Officer
Andrew Albert Kucharchuk MBA
Independent Director
Charles L Rice Jr., MBA
SEC filings
DateFormEvent
30 Jan, 2024 SEC STAFF
18 Jan, 2024 8-K
16 Jan, 2024 8-K CEO Change
29 Nov, 2023 8-K
20 Nov, 2023 10-Q
15 Nov, 2023 NT 10-Q
12 Oct, 2023 8-K
21 Aug, 2023 10-Q
15 Aug, 2023 NT 10-Q
29 Jun, 2023 8-K
22 May, 2023 10-Q
15 May, 2023 NT 10-Q
5 May, 2023 8-K
4 May, 2023 8-K
2 May, 2023 10-K/A
31 Mar, 2023 10-K
8 Mar, 2023 8-K
23 Feb, 2023 8-K
26 Jan, 2023 8-K
2 Dec, 2022 S-1
22 Nov, 2022 8-K
14 Nov, 2022 10-Q
9 Nov, 2022 8-K
6 Oct, 2022 8-K
9 Sep, 2022 8-K CEO Change
25 Aug, 2022 8-K
18 Aug, 2022 DEFA14A
15 Aug, 2022 10-Q
4 Aug, 2022 8-K
6 Jul, 2022 DEFA14A
27 Jun, 2022 DEF 14A
17 Jun, 2022 PRE 14A
16 May, 2022 10-Q
29 Apr, 2022 10-K/A
28 Apr, 2022 3
21 Apr, 2022 3
15 Apr, 2022 10-K
1 Apr, 2022 NT 10-K
29 Nov, 2021 3
22 Nov, 2021 10-Q
16 Nov, 2021 NT 10-Q
12 Nov, 2021 8-K
27 Oct, 2021 8-K
13 Oct, 2021 8-K
24 Aug, 2021 8-K
23 Aug, 2021 10-Q
18 Aug, 2021 8-K
17 Aug, 2021 NT 10-Q
4 Aug, 2021 8-K
24 May, 2021 10-Q
17 May, 2021 NT 10-Q
11 May, 2021 8-K/A
5 May, 2021 8-K
23 Apr, 2021 8-K
7 Apr, 2021 10-K
1 Apr, 2021 NT 10-K
9 Feb, 2021 8-K
Last update:2024-03-08 12:05:14.522972
Adhera Therapeutics, Inc. by TradingView

Sign Up to Subscribe